Literature DB >> 8383879

Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis.

S J Tapscott1, M J Thayer, H Weintraub.   

Abstract

Rhabdomyosarcoma cells express the myogenic helix-loop-helix proteins of the MyoD family but do not differentiate into skeletal muscle cells. Gel shift and transient transfection assays revealed that MyoD in the rhabdomyosarcoma cells was capable of binding DNA but was relatively nonfunctional as a transcriptional activator. Heterokaryon formation with fibroblasts resulted in the restoration of transcriptional activation by MyoD and the differentiation of the rhabdomyosarcoma cells into skeletal muscle cells. These results suggest that rhabdomyosarcomas are deficient in a factor required for MyoD activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383879     DOI: 10.1126/science.8383879

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  87 in total

1.  AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell.

Authors:  Mathivanan Jothi; Kochi Nishijo; Charles Keller; Asoke K Mal
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

2.  Stuck in a balancing act: histone methyltransferase activity of KMT1A traps alveolar rhabdomyosarcomas in an undifferentiated state.

Authors:  Kyle L MacQuarrie; Stephen J Tapscott
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

3.  Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state.

Authors:  Min-Hyung Lee; Mathivanan Jothi; Andrei V Gudkov; Asoke K Mal
Journal:  Cancer Res       Date:  2011-04-14       Impact factor: 12.701

4.  PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1.

Authors:  Wendy Roeb; Antonia Boyer; Webster K Cavenee; Karen C Arden
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-06       Impact factor: 11.205

5.  Comparative analysis of paired- and homeodomain-specific roles in PAX3-FKHR oncogenesis.

Authors:  Youbin Zhang; Joel Schwartz; Chiayeng Wang
Journal:  Int J Clin Exp Pathol       Date:  2008-12-01

6.  Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients.

Authors:  Petr Dmitriev; Luiza Stankevicins; Eugenie Ansseau; Andrei Petrov; Ana Barat; Philippe Dessen; Thomas Robert; Ahmed Turki; Vladimir Lazar; Emmanuel Labourer; Alexandra Belayew; Gilles Carnac; Dalila Laoudj-Chenivesse; Marc Lipinski; Yegor S Vassetzky
Journal:  J Biol Chem       Date:  2013-10-20       Impact factor: 5.157

7.  Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.

Authors:  Hua Wang; Guang-Hua Yang; Hong Bu; Qiao Zhou; Li-Xin Guo; Shou-Li Wang; Lv Ye
Journal:  Int J Exp Pathol       Date:  2003-06       Impact factor: 1.925

8.  MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.

Authors:  Zhihong Yang; Kyle L MacQuarrie; Erwin Analau; Ashlee E Tyler; F Jeffery Dilworth; Yi Cao; Scott J Diede; Stephen J Tapscott
Journal:  Genes Dev       Date:  2009-03-15       Impact factor: 11.361

9.  NeuroD2 and neuroD3: distinct expression patterns and transcriptional activation potentials within the neuroD gene family.

Authors:  M B McCormick; R M Tamimi; L Snider; A Asakura; D Bergstrom; S J Tapscott
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma.

Authors:  Francesca Bersani; Marcello Francesco Lingua; Deborah Morena; Valentina Foglizzo; Silvia Miretti; Letizia Lanzetti; Giovanna Carrà; Alessandro Morotti; Ugo Ala; Paolo Provero; Roberto Chiarle; Samuel Singer; Marc Ladanyi; Thomas Tuschl; Carola Ponzetto; Riccardo Taulli
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.